Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Open in API
Filings indexed 293 across all filing types
Latest filing 2023-12-13 Regulatory Filings
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Alteogen regarding the setting of a record date and shareholder register closure period for the purpose of holding an upcoming Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given its nature as a regulatory notification of a corporate event, it fits best under the RNS category.
2023-12-13 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Alteogen' covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business operations, capital structure, and management discussions, which is characteristic of a formal quarterly financial filing in the Korean market. According to the provided definitions, this falls under the 'Interim / Quarterly Report' category. 9M 2023
2023-11-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal notice regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience (institutional investors), and purpose of the meeting. Since this is an announcement of an event rather than the presentation slides themselves, and it is a regulatory disclosure filed with the Korea Exchange (KRX), it fits the definition of a regulatory filing announcement regarding an investor event.
2023-10-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (sale of shares) by an executive (CFO Lee Sang-mee) of the company Alteogen. This type of filing is a standard regulatory requirement for insider trading/shareholding reporting, which corresponds to the 'Director's Dealing' category.
2023-09-22 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Alteogen Inc., covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, capital structure, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. H1 2023
2023-08-11 Korean
투자판단관련주요경영사항(ALT-B4 관련 마일스톤 기술료 수령)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Alteogen) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the receipt of a milestone payment related to a licensing agreement. This type of disclosure is a standard regulatory requirement for material events in the Korean stock market (KOSDAQ/KRX). Since it does not fit into specific categories like dividends, M&A, or director dealings, it falls under the general regulatory filing category.
2023-05-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.